Table 1.
Mt. Sinai Sample | Valero I | Valero II | SCOPE | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n=233 | n=195 | n=214 | n=179 | ||||||||
Characteristic | n | % | n | % | n | % | n | % | x2 | p | |
Male | 161 | 70 | 134 | 69 | 139 | 65 | 107 | 60 | 1.36 | 0.51 | |
Race | |||||||||||
Caucasian | 133 | 57 | 106 | 54 | 117 | 55 | 102 | 57 | 2.02 | 0.36 | |
African American | 89 | 38 | 74 | 38 | 77 | 36 | 72 | 40 | 0.89 | 0.64 | |
Other or more than 1 | 11 | 5 | 14 | 8 | 20 | 9 | 5 | 3 | 5 | 0.08 | |
Hispanic Ethnicity | 23 | 10 | 23 | 12 | 50 | 23 | 43 | 24 | 19.32 | <0.001 | |
Mean | SD | Mean | SD | Mean | SD | Mean | SD | F | df | p | |
Age (Years) | 58.4 | 7.3 | 44.3 | 11.7 | 41.0 | 12.4 | 38.54 | 13.45 | 158.04 | 2 | <0.001 |
Education | 12.5 | 2.4 | 12.8 | 2.7 | 12.3 | 2.2 | 12.4 | 2.4 | 2.86 | 2 | 0.115 |
Note. Mt. Sinai Patients are from New York; Valero I patients are from Atlanta and San Diego; Valero II patients are from Atlanta, San Diego, and Miami; SCOPE patients are from Miami and Dallas.